万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://onlinelibrary.wiley.com/journal/18686982
3、投稿网址：https://mc.manuscriptcentral.com/jhbps
4、官网邮箱：editorialoffice@jshbps.jp（编辑部）
5、期刊刊期：月刊，一年出版12期。
2021年8月9日星期一
投稿须知【官网信息】
Author Guidelines (Updated on January 2021)
Thank you for your interest in Journal of Hepato-Biliary-Pancreatic Sciences.
Please refer to the full JHBP Author Guidelines for preparing your manuscript.
If your manuscript is ready and you have completed the certification form, please submit your manuscript online.
The Journal of Hepato-Biliary-Pancreatic Sciences
INSTRUCTIONS FOR AUTHORS
UPDATE
•Update on Preprint Policy (3. PREPRINTPOLICY) and Data Sharing Policy (6. Data Sharing Policy)
•Updates on Video Clips (11. PARTS OF MANUSCRIPTS)
•From December 2016, based on the update of Helsinki declaration in 2013, all retrospectively and prospectively designed study which began the study after 1 September 2014 must have the official approval from an appropriate ethical committee. The authors must state the approval number in the method section.
•It is recommended to have the recognition of the institutional reviewer board if possible for retrospectively designed studies which began the study before 1 September 2014. All retrospective study which began their study after 1 September 2014 must write the approval number of the institutional reviewer board in the method section.
•Scientific Fraud and Ethical misconduct In cases of suspected scientific misconduct (fabrication or falsification of data, double publication, duplicate submission, plagiarism, salami slicing), the journal will conduct a preliminary investigation according to the COPEguidelines https://publicationethics.org/resources/guidelines. In case of serious scientific misconduct and ethical breach, the journal might contact the corresponding author’s institution and funding agencies. Editors of JHBPS will consider suspending submission of any papers by the offending authors for a period of 1 year or longer depending on the circumstances of each case.
1. GENERAL
The Journal of Hepato-Biliary-Pancreatic Sciences (JHBPS) publishes original English-language articles dealing with clinical investigations and basic research on all aspects of hepatic, biliary and pancreatic fields. Coverage includes Original Article, Review Article, Special Report, Rapid Communication, Images of Interest, How I do It, and Letters to the Editor and comments on the journal’s policies or content are also included.
2. COPYRIGHT
The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper. Authors may choose to publish under the terms of the journal’s standard copyright transfer agreement (CTA), or under open access terms made available via Wiley OnlineOpen.
3. PREPRINT POLICY
The journal will consider for review articles previously available as preprints. Authors are requested to update any pre-publication versions with a link to the final published article. Authors may also post the final published version of the article immediately after publication. Please read Wiley's Preprint policy.
4. PREREQUISITES FOR PUBLICATION
The editors of JHBPS abide by the recommendations formulated by the International Committee of Medical Journal Editors (ICMJE, www.icmje.org). Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors (www.icmje.org). The main text file should be prepared using Microsoft Word, doubled-spaced, on one side only of A4 paper. The top, bottom and side margins should be 30 mm. All pages should be numbered consecutively in the top right-hand corner, beginning with the first page of the main text file.
Each figure should be supplied as a separate file, with the figure number incorporated in the file name. Forsubmission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high- resolution figures (at least 300 d.p.i.)saved as .eps or .tif files should be uploaded. Digital images supplied only as low-resolution files cannot be used.
5. REGISTRY OF RESEARCH STUDIES INVOLVING HUMAN SUBJECTS
Following the update of Declaration of Helsinki (Fortaleza, Brazil, October 2013), every research study involving human subjects must be registered in a publicly accessible database before recruitment of the first subject. Thus, any research project that assigns human subjects to intervention or comparison groups to study the cause- and-effect relationship between a medical intervention and a health outcome must be registered before recruitment of the first subject. The authors must describe the registration number of the registry in the method section of their study. The above policy applies to every research study which began with enrollment of patients after 1 September 2014. If authors are considering submitting a non-registered prospectively designed research study, please explain the reason why it has not been registered. For manuscript submitted before 31 August 2014, the former policy will be applied which required that only Clinical Trials must be registered. Thus, all Clinical Trials which started after 1 January 2009 must provide the unique registration number at the end of the abstract of the manuscript.
Registration of retrospective studies is recommended but not required; however, authors must have the official approval from an appropriate ethical committee at submission of the study and must describe the approval number in the method section of their study.
Research studies mentioned above should be registered in one of the registries approved by the ICMJE.
The JHBPS accepts registration in the following registries:
•Clinical Trials (http://www.clinicaltrials.gov/)
•Australian New Zealand Clinical Trials
Registry (http://www.anzctr.org.au/)
•ISRCTN Register (http://isrctn.org/)
•Nederlands Trial Register (http://www.trialregister.nl/trialreg/index.a sp)
•UMIN Clinical Trials Registry
(http://www.umin.ac.jp/ctr)
6. DATA SHARING POLICY
The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors may provide a data availability statement, including a link to the repository they have used, in order that this statement can be published in their paper. Shared data should be cited. Please also review Wiley's policy here.”
7. MANUSCRIPT SUBMISSION
Authors must submit their manuscripts online at: https://mc.manuscriptcentral.com/jhbps Upload your manuscript following the instructions given. In case you encounter any difficulties while submitting your manuscript online, click on Help in the upper right corner for FAQ and the most recently updated system requirements.
8. GRAPHICAL TABLE OF CONTENTS
After acceptance, the author must provide a brief description presenting salient and novel findings of the paper in a concise paragraph (word limit: 50 words) and choose a figure or a table which will be highlighted in the online table of contents at the submission of their manuscript. This is only applicable for the following manuscript type: Review Article, Original Article, and Rapid Communication. The author will be asked to provide the description after acceptance from the editorial office. The explanation of the paper will appear in the Table of Contents of the online version of the journal and also in the electronic Table of Contents which will be dispatched to the members of the societies.
9. AUTHORSHIP
The editors of the JHBPS subscribe to the recommendations formulated by the ICMJE regarding criteria for authorship. Accordingly, each person listed as an author or co-author for all submitted manuscript must meet all the following criteria. An author or co-author shall have:
(1)Substantial contributions to the conception or design of the work, or acquisition, analysis or interpretation of data for the work;
(2)Drafting the work or revising it critically for important intellectual content;
(3)Final approval of the version to be published;
(4)Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Meeting these criteria should provide each author with sufficient knowledge of and participation in the work that he or she can accept public responsibility for the report.
Ghost writers are not acceptable. Anyone who has contributed in drafting the manuscript should be included as an author if they meet the above criteria for authorship; otherwise whoever has contributed should be mentioned in the acknowledgment section with any financial support fully disclosed.
Guidelines, Consensus Statement and Multi-center Studies (including Project Studies) will be defined as Multi-author group articles. The number of authors for Multi-center Studies can be 10 or more.
Name of collaborators who have provided data or co-operated substantially to the research but do not meet the criteria as an author should be listed in the acknowledgment section.
For large survey studies, also contact the editorial office about the procedure of submission and confirmation of authorship of the article. Survey studies will be published as Original Article and will be made free online after publication.
Name of collaborators who have provided data or co-operated substantially to the survey but do not meet the criteria as an author should be listed in the acknowledgment section.
10. PREPARATION OF MANUSCRIPTS
All manuscripts must be written in English, typed double-spaced with wide margins throughout. Manuscripts that have been extensively modified in the editorial process will be returned to the author for retyping. Incomplete or improperly prepared manuscripts will be returned to authors without review.
(1)ORIGINAL ARTICLE
Authors: Maximum 10
Word limit: 4,000 words including
abstract but excluding references, tables and figures
Abstract: 200 words maximum, structured
References: Up to 30 in total
Figure & Table: Up to 7
Keyword: 5 key words
(2)REVIEW ARTICLE
Authors: Maximum 6
Word limit: 5,000 words including
abstract but excluding references, tables and figures
Abstract: 200 words maximum,unstructured
References: Up to 100 in total
Figure & Table: Up to 7
Keyword: 5 key words
(3)SYSTEMATIC REVIEW
Authors: Maximum 6
Word limit: 5,000 words including
abstract but excluding references, tables and figures
Abstract: 200 words maximum,structured
References: Up to 100 in total
Figure & Table: Up to 7
Keyword: 5 key words
(4)GUIDELINE (After proposal outline)
Authors: No limit
Abstract: 200 words maximum,structured
Keyword: 5 key words
Word limit, References, Figure & Table: To be determined in consultation with Editors
Description: Proposals for guidelines
should be submitted prior to submission;however, in this case authors should only send an outline of the proposed paper for initial consideration.
(5)CONSENSUS STATEMENT (After proposal outline)
Authors: No limit
Abstract: 200 words maximum,structured
Keyword: 5 key words
Word limit, References, Figure & Table: To be determined in consultation with Editors
Description: Proposals for consensus statement should be submitted prior to submission; however, in this case authors should only send an outline of the proposed paper for initial consideration.
(6)TOPIC (By invitation)
Authors: Maximum 10
Word limit: 4,000 words including abstract but excluding references, tables and figures
Abstract: 200 words maximum, structured
References: Up to 30 in total
Figure & Table: Up to 7
Keyword: 5 key words
(7)PLENARY SESSION (Selected papers at
Congress)
Authors: Maximum 10
Word limit: 4,000 words including abstract but
excluding references, tables and figures Abstract: 200 words maximum, structured References: Up to 30 in total
Figure & Table: Up to 7
Keyword: 5 key words
Description: Plenary sessions presented at the annual meeting of the Japanese Society of Hepato-Biliary-Pancreatic Surgery and selected for publication in the Journal.
(8)RAPID COMMUNICATION
Authors: Maximum 10
Word limit: 400 words excluding references
Abstract: No abstract
References: Up to 3
Figure & Table: Up to 1
Description: Brief presentations of new, noteworthy research and clinical results.
(9)HOW I DO IT (with video) <Online Only>
Authors: Maximum 10
Word limit: 300 words excluding references
Abstract: No abstract
References: Up to 5
Figure & Table: Up to 2
Description: Original, high-quality video with extraordinary techniques are considered for publication.
(10)IMAGE OF INTEREST <Online Only>
Authors: Maximum 3
Word limit: 300 words excluding references
Abstract: No abstract
References: Up to 5
Figure & Table: Up to 2
Description: Original, high-quality images or video with extraordinary findings are considered for publication.
(11)LETTER TO THE EDITOR <Online Only>
Authors: Maximum 3
Word limit: 500 words excluding references
Abstract: No abstract
References: Up to 5
Figure & Table: Up to 1
Description: Differences of opinion or supporting views of previously published editorials or recently published articles. Only publish online with a distinctive e-page numbering and will be free online.
(12) SPECIAL REPORT
If an author wants to submit a special report,
please contact the Editor-in-Chief at:
editorialoffice@jshbps.jp prior to submission.
(13)EDITORIAL (By invitation)
Authors: Maximum 3
Word limit: 1,000 words excluding references, tables and figures Abstract:No abstract
References: Up to 5
Figure & Table: Up to 2
……
更多详情：
https://onlinelibrary.wiley.com/pb-assets/assets/18686982/JHBPS_author_guidelines_10Feb2021_REV-1620605864783.pdf
